Allergic bronchopulmonary aspergillosis in patients with Cystic Fibrosis
DOI:
https://doi.org/10.33448/rsd-v10i7.17227Keywords:
Cystic fibrosis; Aspergillus fumigatus; Allergic bronchopulmonary aspergillosis.Abstract
Cystic fibrosis (CF) is a genetic disease of autosomal recessive profile and is characterized by dysfunction of the CFTR gene, which will affect some organs such as the lungs, pancreas, liver, intestines, and testes, with the lungs being the most characteristic. Such changes are capable of causing consistent obstructions due to the viscous mucus produced. Infections are a recurrent factor in carriers of this disease due to the presence of secretion, becoming an ideal environment for the propagation of microorganisms, such as fungi and bacteria, which can colonize the airways of patients and bring about an aggravation, worsening the patient's clinical picture. This is the case of the fungus Aspergillus fumigattus, the cause of allergic bronchopulmonary aspergillosis (ABPA), which can lead to relevant complications, especially in lung function. Analyzing the factors that make CF patients more likely to contract ABPA and how this can worsen their clinical condition, searching for materials from the PUBMED and SCIELO platforms, using the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), the results obtained in this study show that the presence of ABPA in cystic fibrosis patients brings increased microbial colonization, lung deterioration, poorer nutritional status, and greater respiratory obstruction by mucus that causes a greater increase in hospitalization.
References
Aguiar, S. S., Damaceno, N. & Forte, W. C. N. (2017). Tests to assess sensitization to Aspergillus fumigatus in cystic fibrosis. Revista Paulista de Pediatria, 35(3), 252–257. https://doi.org/10.1590/1984.0462/;2017;35;3;00003
Agarwal, R. (2012). Aspergilose broncopulmonar alérgica - tratamento. American Review Of Respiratory Disease, 2–3.
Almeida, M. B., Bussamra, M. H. C. F. & Rodrigues, J. C. (2006). ABPA diagnosis in cystic fibrosis patients: The clinical utility of IgE specific to recombinant Aspergillus fumigatus allergens. Jornal de Pediatria, 82(3), 215–220. https://doi.org/10.2223/JPED.1479
Alyasin, S., Moghtaderi, M., Farjadian, S., Babaei, M. & Hosseini Teshnizi, S. (2018). Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis and non-cystic fibrosis bronchiectasis. Electronic Physician, 10(1), 6273–6278. https://doi.org/10.19082/6273
Breuer, O., Schultz, A., Garratt, L. W., Turkovic, L., Rosenow, T., Murray, C. P., Karpievitch, Y. V., Akesson, L., Dalton, S., Sly, P. D., Ranganathan, S., Stick, S. M. & Caudri, D. (2020). Aspergillus infections and progression of structural lung disease in children with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine, 201(6), 688–696. https://doi.org/10.1164/rccm.201908-1585OC
Carneiro, A. C. C., Lemos, A. C. M., Arruda, S. M. & Santana, M. A. P. S. (2008). Prevalência de aspergilose broncopulmonar alérgica em pacientes com fibrose cística na Bahia, Brasil. Jornal Brasileiro de Pneumologia, 34(11), 900–906. https://doi.org/10.1590/S1806-37132008001100003
César, M. & Castro, S. De. (2011). O Tratamento na Fibrose Cística e suas Complicações. Revista Hospital Universitário Pedro Ernesto, 10(4). https://doi.org/10.12957/rhupe.2011.8882v
Firmida, M. D. C. (2011). Fisiopatologia e Manifestações Clínicas da Fibrose Cística. Revista Hospital Universitário Pedro Ernesto, 10(4). https://doi.org/10.12957/rhupe.2011.8878
Hong, G., Psoter, K. J., Jennings, M. T., Merlo, C. A., Boyle, M. P., Hadjiliadis, D., Kawut, S. M. & Lechtzin, N. (2018). Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis. Journal of Cystic Fibrosis, 17(5), 624–630. https://doi.org/10.1016/j.jcf.2018.01.008
Hoffmann, A. & Procianoy, E. da F. A. (2011). Infecção respiratória na fibrose cística e tratamento. Clinical and Biomedical Research, 31(2).
Itens, P., Revis, R. & Uma, P. (2015). Principais itens para relatar Revisões sistemáticas e Meta-análises: A recomendação PRISMA. Epidemiologia e Serviços de Saúde, 24(2), 335–342. https://doi.org/10.5123/s1679-49742015000200017
Lattanzi, C., Messina, G., Fainardi, V., Tripodi, M. C., Pisi, G. & Esposito, S. (2020). Allergic bronchopulmonary aspergillosis in children with cystic fibrosis: An update on the newest diagnostic tools and therapeutic approaches. Pathogens, 9(9), 1–13. https://doi.org/10.3390/pathogens9090716
Marmitt, D. J., Rempel, C., Goettert, M. I. & Silva, A. C. (2015). Plantas Medicinais da RENISUS Com Potencial Anti-inflamatório: Revisão Sistemática Em Três Bases de Dados Científicas. Revista Fitos, 9(2). https://doi.org/10.5935/2446-4775.20150011
Maleki, M., Mortezaee, V., Hassanzad, M., Mahdaviani, S. A., Poorabdollah, M., Mehrian, P., Behnampour, N., Mirenayat, M. S., Abastabar, M., Tavakoli, M. & Hedayati, M. T. (2020). Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis patients using two different diagnostic criteria. European Annals of Allergy and Clinical Immunology, 52(3), 104–111. https://doi.org/10.23822/EurAnnACI.1764-1489.121
Sancho-García, I. & Piñero-Zapata, M. (2021). Aumento de eventos cardiovasculares en pacientes tratados con clopidogrel y omeprazol simultáneamente: una revisión sistemática. Evidentia, 18, e12814. https://doi.org/10.1371/journal.pmed1000097
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Reinaldo José dos Santos Júnior; Natália Millena Silva; Pâmella Grasielle Vital Dias de Souza
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
